Literature DB >> 3686322

Surgery of incidental intracranial aneurysms.

O Heiskanen1, A Poranen.   

Abstract

A series of nine patients with an unruptured asymptomatic aneurysm not associated with a ruptured aneurysm is discussed. Three had giant aneurysms. Two patients had bilateral aneurysms of the middle cerebral artery. Five had solitary aneurysms of the middle cerebral artery. One had an aneurysm of the anterior communicating artery. One had an ophthalmic aneurysm. All aneurysms were clipped. Two operations were necessary in the two patients with bilateral aneurysms. There was no mortality and no significant morbidity. Clipping of the aneurysm is recommended for those patients who have no other serious illness that significantly increases the surgical risk. If a combination of pituitary tumor and aneurysm is found, a subfrontal instead of transsphenoidal approach should be considered so as to treat both the tumor and aneurysm at the same operation.

Entities:  

Mesh:

Year:  1987        PMID: 3686322     DOI: 10.1016/0090-3019(87)90225-4

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  3 in total

1.  Surgical treatment of brain tumor coexisted with intracranial aneurysm--case series and review of the literature.

Authors:  Zhihong Zhong; Yuhao Sun; Dong Lin; Qingfang Sun; Liuguan Bian
Journal:  Neurosurg Rev       Date:  2013-05-25       Impact factor: 3.042

2.  Long-term prognosis in patients with clipped unruptured cerebral aneurysms--increased cerebrovascular events in patients with surgically treated unruptured aneurysms.

Authors:  Masaaki Hokari; Satoshi Kuroda; Naoki Nakayama; Kiyohiro Houkin; Tatsuya Ishikawa; Hiroyasu Kamiyama
Journal:  Neurosurg Rev       Date:  2013-04-19       Impact factor: 3.042

3.  Surgical management of unruptured intracranial aneurysms. Personal experience with 37 cases and discussion of the indications.

Authors:  R Deruty; I Pelissou-Guyotat; C Mottolese; L Bognar; A Oubouklik
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.